PPD development site & study monitoring

Ended Purchase Order Awarded Last action

Contract number
HHSN271201700007A
Awardee
Awarding agency
Obligated
$696,693

Award facts

Opportunity
Contract value 100% obligated
$696,693.16 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Cape Fear, NC 28401, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 -$432,696
Funding Only Action P00010 -$143,205
Other Administrative Action P00009 $0
Funding Only Action P00008 · Study and site monitoring services -$17,010
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope P00006 · Extend the POP: 5/26/2021-5/25/2022 for study and site monitoring services. PPD development LP:1106692 [18-000365] $26,846
Exercise an Option P00005 · Option 3 POP: 5/26/2020-5/25/2021 for study and site monitoring services. PPD development LP:1106692 [18-000365] $397,067
Exercise an Option P00004 $297,468
Exercise an Option 3 · Option 1 POP: 5/26/2018-5/25/2019 for study and site monitoring services. PPD development LP:1106692 [18-000365] $291,418
Other Administrative Action 2 · PPD development LP:1106692 [18-000365] $0
Other Administrative Action 1 $0
Original award $276,805
Show all 12

About this award

This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $696,693.16, was awarded to PPD Development LP, a global contract research organization (CRO), to provide PPD development site and study monitoring services. The contract has no set-aside designation and is part of several indefinite delivery contracts (IDCs) that PPD holds with NIDA, the National Cancer Institute (NCI), and the Defense Health Agency to support a wide range of clinical research and development initiatives, including those focused on infectious diseases, neurological disorders, substance use disorders, and medical device innovation. This contract is part of NIDA's portfolio of research programs and studies.

Quick answers

Who was awarded contract HHSN271201700007A?

HHSN271201700007A was awarded to PPD Development LP by National Institute on Drug Abuse (National Institutes of Health) on May 12, 2017.

How much is contract HHSN271201700007A worth?

The government has obligated $696,693 on HHSN271201700007A.

Was contract HHSN271201700007A competed?

The extent of competition for HHSN271201700007A was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award